• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

TAVR Offers Alternative for Cardiac Patients Who Cannot Undergo Surgery

The TAVR device is deployed through a catheter to inflate a balloon that opens the new valve

The TAVR device is deployed through a catheter to inflate a balloon that opens the new valve. Photo: Lisa Worthley

UCLA performed its first transcatheter aortic valve replacement (TAVR) in August, using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery.

Although minimally invasive surgical procedures have been used on the aortic valve in the past, these operations relied on incisions in the chest wall and required cardiopulmonary bypass. The TAVR allows doctors for the first time to replace the aortic valve without either of these components of conventional surgery.

Many patients are not good candidates for conventional valve replacement because they suffer from a number of other health issues, and it is estimated that 40 percent of patients do not undergo aortic-valve replacement because they cannot tolerate surgery.

The new device is deployed through a catheter - a long tube that is advanced through an artery in the groin up to the heart. Once the valve is in place, a balloon at the end of the catheter is inflated, opening the new valve, which starts working instantly. Studies have shown the new valve procedure dramatically improves quality of life and survival rates.

A recent randomized clinical study showed a significantly higher one-year survival rate among patients treated with the new valve, compared with those who received medical therapy.

"We expect to see substantial quality-of-life gains from this new procedure," says Richard J. Shemin, M.D., chief of cardiothoracic surgery. "Many patients who were formerly bedridden will be able to resume a more normal life with this novel new therapy."

For more information about the TAVR procedure at UCLA and to view a video, go to: heart.ucla.edu/tavr


Previous
2,000 and Counting
Next
Can Obesity Help One to Survive Heart Failure?


YOU ARE VIEWING

Winter 2013

Winter 2013
E-Brochure
Printable PDF
IN THIS ISSUE
  • Hope and Pride
  • Beating the Odds: "I'm Alive!"
  • Zeroing In on Autism Genes
  • ‘Breathing-Lung’ Transplant Makes History
  • What Makes Our Brains Human? It’s in the Wiring
  • 2,000 and Counting
  • TAVR Offers Alternative for Cardiac Patients Who Cannot Undergo Surgery
  • Can Obesity Help One to Survive Heart Failure?
  • Can Diet Help Heal Spinal-Cord Injury?
  • Ray of Hope in Fight against Duchenne MD
  • Meditation Reduces Loneliness
  • A One-Two Punch to Skin Cancer
  • Barbara Natterson-Horowitz, M.D.
  • Brain Trust
  • Three Who Stood Up
  • At Home in the Hospital
  • How Doctors Think
  • The Fashion Doctor
  • Awards/Honors
  • In Their Own Words: Tactical-Medicine Physicians
  • Postcard from Skid Row
  • MAA Alumnus of the Year
  • 2012-13 MAA Executive Board Members
  • On the Road
  • Calendar
  • Working Today for Today’s and Tomorrow’s Children
  • Raising Awareness of Ovarian Cancer
  • Events
  • Gifts
  • Chairs of Distinction
  • Lessons Learned: Get Up and Go See the Patient
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth